Figure S1. LPS induces cytokines expression in HOKs. (A and B) Real-time PCR quantification of HOKs treated with time course-dependent LPS (100 ng/ml) or saline (A) and concentration-dependent LPS or saline (B) as indicated. (C and D) Elisa measurements of HOKs treated with time course-dependent LPS (100 ng/ml) or saline (C) and concentration-dependent LPS or saline (D) as indicated. *P < 0.05, **P < 0.01, ***P < 0.001 vs. corresponding controls; All assays were conducted for three times, n = 3. (TIF 634 kb
Figure S1. Gene expression profile of microglia and THP-1 cells under LPS challenge and ibuprofen pr...
Effects of tofacitinib pretreatment (30 min) on pro-interleukin-1 beta (pro-IL-1β) and NLR family py...
Figure S1. Gene expression levels over passages. The expression levels of VCAM-1, ICAM-1, IL-7 and P...
Figure S2. The effects of chetomin and IMD-0354 on HIF-1α in HOKs and TREM-1 expression in human bio...
is Figure S2 showing treatment of MAPK inhibitors to AF cells with ROS. Real-time RT-PCR analysis of...
RELA activation following LPS treatment and binding at super-enhancers. A: Detroit 562 cells were tr...
Additional file 1. Supplemental figure 1. VDR levels are decreased in mouse oral and colonic epithel...
Figure S1. Purity of microglia cells in culture assessed by immunofluorescence detection of Iba-1- (...
LPAR5 controls LPA-mediated downstream signaling. (A) BV-2 microglia cells were cultured in 6-well p...
Figure S1. Changes of inflammation-associated protein expression in an endotoxemic mouse. Male C57BL...
Figure S1. IL-6 mRNA expression in peritoneal cavity tissues after LPS challenge. Figure S2. Intrace...
Figure S1. Toll-like receptor signaling pathway including innate and adaptive immune response genes ...
Detailed methods: lentiviral production and transduction, metabolic assays, and list of reagents for...
Figure S1. Oxidative microenvironment in the colonic mucosa of AOM-treated mice. (a) Real-time PCR f...
PKD family inhibition abrogates LPA-mediated downstream signaling. (A) BV-2 microglia cells were cul...
Figure S1. Gene expression profile of microglia and THP-1 cells under LPS challenge and ibuprofen pr...
Effects of tofacitinib pretreatment (30 min) on pro-interleukin-1 beta (pro-IL-1β) and NLR family py...
Figure S1. Gene expression levels over passages. The expression levels of VCAM-1, ICAM-1, IL-7 and P...
Figure S2. The effects of chetomin and IMD-0354 on HIF-1α in HOKs and TREM-1 expression in human bio...
is Figure S2 showing treatment of MAPK inhibitors to AF cells with ROS. Real-time RT-PCR analysis of...
RELA activation following LPS treatment and binding at super-enhancers. A: Detroit 562 cells were tr...
Additional file 1. Supplemental figure 1. VDR levels are decreased in mouse oral and colonic epithel...
Figure S1. Purity of microglia cells in culture assessed by immunofluorescence detection of Iba-1- (...
LPAR5 controls LPA-mediated downstream signaling. (A) BV-2 microglia cells were cultured in 6-well p...
Figure S1. Changes of inflammation-associated protein expression in an endotoxemic mouse. Male C57BL...
Figure S1. IL-6 mRNA expression in peritoneal cavity tissues after LPS challenge. Figure S2. Intrace...
Figure S1. Toll-like receptor signaling pathway including innate and adaptive immune response genes ...
Detailed methods: lentiviral production and transduction, metabolic assays, and list of reagents for...
Figure S1. Oxidative microenvironment in the colonic mucosa of AOM-treated mice. (a) Real-time PCR f...
PKD family inhibition abrogates LPA-mediated downstream signaling. (A) BV-2 microglia cells were cul...
Figure S1. Gene expression profile of microglia and THP-1 cells under LPS challenge and ibuprofen pr...
Effects of tofacitinib pretreatment (30 min) on pro-interleukin-1 beta (pro-IL-1β) and NLR family py...
Figure S1. Gene expression levels over passages. The expression levels of VCAM-1, ICAM-1, IL-7 and P...